Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Randy Werneth
AddedFeb 15, 2024
UpdatedMay 31, 2026
Randy Werneth

Randy Werneth

Board Member, Acutus Medical

CrunchbaseLinkedInThe Org

Randy Werneth's Career

Acutus Medical
Acutus Medical

Carlsbad, CA, US

Board Member· Board
Maxwell Biomedical
Maxwell Biomedical

San Diego, CA, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Randy Werneth's Career

Acutus Medical
Acutus Medical
Acquired$343.2M02011Carlsbad, CA, US
Board Member· Board

Leadership at Acutus Medical

Kevin JohnsonKevin JohnsonBoard Member
Shaden MarzoukShaden MarzoukBoard Member
Andrew ElbardissiAndrew ElbardissiBoard Member
Scott HuennekensScott HuennekensBoard Member
Jason GarlandJason GarlandBoard Member
John SheridanJohn SheridanBoard Member

Similar to Acutus Medical

AtriCureAtriCureMason, OH, USPain Management, Surgical Devicesest. 2000AtriCureMason, OH, US · est. 2000

AtriCure, Inc. develops and sells surgical devices for precise lesion creation in soft tissues, serving customers globally.

Public · $26M260
AtaCor MedicalAtaCor MedicalSan Clemente, CA, USMedical Devicesest. 2014AtaCor MedicalSan Clemente, CA, US · est. 2014

AtaCor Medical Inc.: Innovating cardiac pacing solutions as a leading medical device maker.

Series B · $34M23
Atrility MedicalAtrility MedicalMadison, WI, USMedical Devicesest. 2017Atrility MedicalMadison, WI, US · est. 2017

Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.

Series A · $4M9
CoreMapCoreMapBurlington, VT, USMedical Devicesest. 2016CoreMapBurlington, VT, US · est. 2016

CoreMap: Enhancing patient outcomes with advanced diagnostic technology for electrophysiologists.

Series A · $33.8M35
Maxwell Biomedical
Maxwell Biomedical
Seed$8M142019San Diego, CA, US
CEO· C-Suite · Management

Leadership at Maxwell Biomedical

Mehdi RazaviMehdi RazaviCo-Founder
Aydin BabakhaniAydin BabakhaniBoard Member

Similar to Maxwell Biomedical

MediCool TechnologiesMediCool TechnologiesRochester, MN, USMedical Devicesest. 2015MediCool TechnologiesRochester, MN, US · est. 2015

MediCool Technologies: Painless solutions for preventing and treating cardiac arrhythmias.

Seed · $896k6
Medical Device InnovationsMedical Device InnovationsEscondido, CA, USMedical Devicesest. 2010Medical Device InnovationsEscondido, CA, US · est. 2010

ION Medical develops novel, easy-to-use tech for Atrial Fibrillation & Hypertension treatment, focusing on safety & long-term effectiveness.

Pre-Seed · $701.7k30
Atrility MedicalAtrility MedicalMadison, WI, USMedical Devicesest. 2017Atrility MedicalMadison, WI, US · est. 2017

Cardiac device manufacturer setting new standards in arrhythmia monitoring with AtriAmp.

Series A · $4M9
CardioFocusCardioFocusMarlborough, MA, USMedical Devicesest. 1990CardioFocusMarlborough, MA, US · est. 1990

US-based CardioFocus advances ablation treatments for cardiac disorders through biotechnology.

Public · $268M71

Randy Werneth's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Randy Werneth

Joshua McClureJoshua McClureBoard Member · Maxwell BiosciencesJohn PaasonenJohn PaasonenCo-Founder · Maxwell FinancialJacob BalmaJacob BalmaCo-Founder · Maxwell LabsMaxim MikheevMaxim MikheevFounder & CEO · BiomedicanAlireza HassaniAlireza HassaniFounder · Maxwellian